LIANY
LianBio
-0.00 (-0.83%)0.06USD60成交股數6.4M市值–本益比(近四季)0.7股價營收比+92.7%營收年增(近四季)–下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 23Q3 | 23Q2 | 23Q1 | 22Q4 | 22Q3 | 22Q2 | 22Q1 | 21Q3 | 21Q2 | 21Q1 | 20Q4 | 20Q3 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 2.7M+93% | 2.8M+398% | 2.4M+759% | 2.1M+6409% | 1.4M+1225% | 553K+1576% | 280K | 32K-102% | 106K | 33K | – | −1.3M |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 9.0M | 9.5M | 10.8M | 10.6M | 8.3M | 28.6M | 12.3M | 4.7M | 93.0M | 53.4M | – | 117M |
| 銷售管理費用 | 17.3M | 15.6M | 15.1M | 18.7M | 16.3M | 14.6M | 16.1M | 8.9M | 6.5M | 7.1M | – | 2.1M |
| 營業利益 | −26.3M+7% | −25.0M-42% | −26.0M-9% | −29.2M+116% | −24.5M-75% | −43.1M-29% | −28.4M | −13.5M-89% | −99.5M | −60.5M | – | −119M |
| 營業利益率 | -971.6% | -909.4% | -1,079.3% | -1,404.0% | -1,747.3% | -7,801.4% | -10,148.9% | -42,325.0% | -93,859.4% | -183,330.3% | – | 9,206.8% |
| 稅後淨利 | −24.0M+10% | −21.6M-49% | −24.0M-13% | −18.3M+39% | −21.9M-78% | −42.4M-31% | −27.7M+118% | −13.1M-89% | −100M | −61.6M | −12.7M | −120M |
| 淨利率 | -888.0% | -785.1% | -999.4% | -877.4% | -1,558.5% | -7,665.6% | -9,902.1% | -40,975.0% | -94,743.4% | -186,560.6% | – | 9,299.1% |
| 稀釋 EPS | -0.22+10% | -0.20-49% | -0.22-15% | -0.17-73% | -0.20-96% | -0.39-87% | -0.26 | -0.63-95% | -4.90 | -3.01 | – | -11.71 |
| 稀釋股數 | 107M | 107M | 107M | 108M | 108M | 108M | 107M | 20.7M | 20.5M | 20.5M | 12.1M | 10.3M |
資產負債表 期末餘額
| 科目 | 23Q3 | 23Q2 | 23Q1 | 22Q4 | 22Q3 | 22Q2 | 22Q1 | 21Q3 | 21Q2 | 21Q1 | 20Q4 | 20Q3 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 103M | 104M | 102M | 79.2M | 78.9M | 134M | 140M | 109M | 143M | 235M | 254M | 8.6M |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 263M | 279M | 303M | 320M | 352M | 372M | 413M | 142M | – | – | 279M | – |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 26.8M | 23.3M | 28.2M | 26.3M | 45.2M | 45.6M | 48.7M | 42.3M | – | – | 27.6M | – |
| 股東權益 | 202M | 222M | 241M | 260M | 273M | 292M | 331M | −297M | −247M | −149M | −133M | −103M |
| 負債比 | 10.2% | 8.4% | 9.3% | 8.2% | 12.9% | 12.3% | 11.8% | 29.8% | – | – | 9.9% | – |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 23Q3 | 23Q2 | 23Q1 | 22Q4 | 22Q3 | 22Q2 | 22Q1 | 21Q3 | 21Q2 | 21Q1 | 20Q4 | 20Q3 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | – | −17.6M+35% | – | – | – | −13.1M | – | – | −1.9M | – | – |
| 資本支出 | – | – | 19K | – | – | – | 344K | – | – | 29K | – | – |
| 自由現金流 | – | – | −17.7M+31% | – | – | – | −13.4M | – | – | −1.9M | – | – |
| 折舊攤銷 | – | – | – | – | – | – | – | – | – | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | -733.6% | – | – | – | -4,801.8% | – | – | -5,878.8% | – | – |
營收拆解
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2022 | 4.3M | +1678.2% | −110M | -2,552.4% | -1.02 | −101M |
| FY2021 | 243K | -105.0% | −196M | -80,781.9% | -5.71 | −165M |
| FY2020 | −4.9M | – | −140M | 2,876.1% | -11.58 | −99.0M |